China · Delayed Price · Currency is CNY Beijing SL Pharmaceutical Statistics
Total Valuation
SHE:002038 has a market cap or net worth of CNY 6.59 billion. The enterprise value is 5.64 billion.
| Market Cap | 6.59B |
| Enterprise Value | 5.64B |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
SHE:002038 has 1.03 billion shares outstanding. The number of shares has increased by 4.23% in one year.
| Current Share Class | 1.03B |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | +4.23% |
| Shares Change (QoQ) | +22.72% |
| Owned by Insiders (%) | 23.27% |
| Owned by Institutions (%) | 1.55% |
| Float | 628.56M |
Valuation Ratios
The trailing PE ratio is 81.02.
| PE Ratio | 81.02 |
| Forward PE | n/a |
| PS Ratio | 11.38 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 71.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.46, with an EV/FCF ratio of -19.74.
| EV / Earnings | 67.32 |
| EV / Sales | 9.75 |
| EV / EBITDA | 40.46 |
| EV / EBIT | n/a |
| EV / FCF | -19.74 |
Financial Position
The company has a current ratio of 12.37
| Current Ratio | 12.37 |
| Quick Ratio | 5.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.47% and return on invested capital (ROIC) is -0.45%.
| Return on Equity (ROE) | 1.47% |
| Return on Assets (ROA) | -0.20% |
| Return on Invested Capital (ROIC) | -0.45% |
| Return on Capital Employed (ROCE) | -0.33% |
| Weighted Average Cost of Capital (WACC) | 6.06% |
| Revenue Per Employee | 650,855 |
| Profits Per Employee | 94,227 |
| Employee Count | 889 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.69 |
Taxes
| Income Tax | -20.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.04% in the last 52 weeks. The beta is 0.33, so SHE:002038's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -5.04% |
| 50-Day Moving Average | 7.68 |
| 200-Day Moving Average | 7.47 |
| Relative Strength Index (RSI) | 24.54 |
| Average Volume (20 Days) | 28,363,979 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002038 had revenue of CNY 578.61 million and earned 83.77 million in profits. Earnings per share was 0.08.
| Revenue | 578.61M |
| Gross Profit | 361.13M |
| Operating Income | -19.22M |
| Pretax Income | 62.28M |
| Net Income | 83.77M |
| EBITDA | 139.38M |
| EBIT | -19.22M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 953.57 million in cash and n/a in debt, with a net cash position of 953.57 million or 0.93 per share.
| Cash & Cash Equivalents | 953.57M |
| Total Debt | n/a |
| Net Cash | 953.57M |
| Net Cash Per Share | 0.93 |
| Equity (Book Value) | 5.70B |
| Book Value Per Share | 5.54 |
| Working Capital | 2.38B |
Cash Flow
In the last 12 months, operating cash flow was 91.82 million and capital expenditures -377.53 million, giving a free cash flow of -285.70 million.
| Operating Cash Flow | 91.82M |
| Capital Expenditures | -377.53M |
| Free Cash Flow | -285.70M |
| FCF Per Share | -0.28 |
Margins
Gross margin is 62.41%, with operating and profit margins of -3.32% and 14.48%.
| Gross Margin | 62.41% |
| Operating Margin | -3.32% |
| Pretax Margin | 10.76% |
| Profit Margin | 14.48% |
| EBITDA Margin | 24.09% |
| EBIT Margin | -3.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | -86.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 24.53% |
| Buyback Yield | -4.23% |
| Shareholder Yield | -3.97% |
| Earnings Yield | 1.27% |
| FCF Yield | -4.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 4, 2019. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 4, 2019 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:002038 has an Altman Z-Score of 15.36 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.36 |
| Piotroski F-Score | 4 |